Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06218550 · ClinicalTrials.gov registry record · Phase 1
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT06218550: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT06218550 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06218550, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Delta-8-THC is an isomer of delta-9-THC that has become widely available due to the legalization of hemp and its derivatives. Very little controlled research has been conducted with delta-8-THC and some research suggests it produces similar effects to delta-9-THC, albeit at lower potency. The present study will evaluate the dose effects of delta-8-THC, compared with delta-9-THC, on simulated driving performance, field sobriety tests, cognitive performance, and biomarkers of exposure to cannabinoids. The results will inform policy and education related to impairment due to acute delta-8-THC exposure via vaporization and oral ingestion.
Interventions
- DRUG Placebo
- DRUG Delta-9-THC
- DRUG Delta-8-THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2025-09-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06218550
The ClinicalTrials.gov registry entry for NCT06218550 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06218550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06218550 about?
NCT06218550 is a clinical study titled "Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance". Delta-8-THC is an isomer of delta-9-THC that has become widely available due to the legalization of hemp and its derivatives. Very little controlled research has been conducted with delta-8-THC and some research suggests it produces similar effects to delta-9-THC, albeit at lower potency. The presen...
What is the current status of trial NCT06218550?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2024-07-01. Estimated completion is 2025-09-08.
What interventions are being tested in trial NCT06218550?
The interventions under investigation include: Placebo (DRUG), Delta-9-THC (DRUG), Delta-8-THC (DRUG).
Who is sponsoring clinical trial NCT06218550?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.